Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | PF-08046032 |
| Trade Name | |
| Synonyms | PF 08046032|PF08046032 |
| Drug Descriptions |
PF-08046032 is an antibody-drug conjugate (ADC) comprising an antibody targeting CD25 linked to monomethyl auristatin E, which potentially results in Treg depletion in the tumor microenvironment and increased antitumor immune response (Journal for ImmunoTherapy of Cancer 2024;12). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| PF-06801591 + PF-08046032 | PF-06801591 PF-08046032 | 0 | 1 |
| PF-08046032 | PF-08046032 | 0 | 1 |